Customer Notification / Recall for Valsartan Containing Drug Products
Voluntary recall of Valsartan and Valsartan-containing products in compliance with the product recall issued by the US FDA, European Medicines Agency (EMA) due to discovery of impurity, N-nitroso dimethylamine (NDMA) in the Active Pharmaceutical Ingredient (API), Valsartan manufactured by Zhejiang Huahai Pharmaceuticals in Linhai China.
